Browse all clinical trials

Sponsor Updatedsort icon
Phase III A Phase III Study of Dasatinib vs. Imatinib in Patients With Newly Diagnosed Chronic Phase CML Bristol-Myers Squibb 2009-05-20
Phase I BMS-582664 in Combination With Erbitux in Patients With Advanced Gastrointestinal Malignancies Bristol-Myers Squibb 2009-05-20
Phase I Open Label Study of a Single Dose of a New Extended Long Acting Formulation of Octreotide Pamoate in Healthy Volunteers Novartis Pharmaceuticals 2009-05-20
Linkage Analysis in Interstitial Cystitis National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 2009-05-20
Brain Activity in Time Discrimination and Sensory Input National Institute of Neurological Disorders and Stroke (NINDS) 2009-05-20
Computer-Assisted Self-Administration of Ethanol National Institute on Alcohol Abuse and Alcoholism (NIAAA) 2009-05-20
Phase I A Phase 1/2 Study of Epofolate (BMS-753493) in Subjects With Advanced Cancer (Schedule 2) Bristol-Myers Squibb 2009-05-20
Phase I A Single Ascending Dose Study of BMS-791325 in HCV Infected Subjects Bristol-Myers Squibb 2009-05-20
Phase III Phase 3, Randomized, Double-Blind, Placebo-Controlled, Trial of Linaclotide Administered to Patients With Chronic Constipation Forest Laboratories 2009-05-20
Phase III Cyclophosphamide and Prednisone With or Without Immunoglobulin in Treating Abnormal Muscle Movement in Children With Neuroblastoma National Cancer Institute (NCI) 2009-05-20
Phase III Study of an Investigational Drug for the Prevention of Thrombosis-Related Events Following Knee Replacement Surgery Bristol-Myers Squibb 2009-05-20
Phase III Efficacy and Safety Study of Apixaban for the Treatment of Deep Vein Thrombosis or Pulmonary Embolism Bristol-Myers Squibb 2009-05-20
Phase I Vaccine Therapy and GM-CSF in Treating Patients With Stage III or Stage IV Breast Cancer or Ovarian Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Paclitaxel, Cisplatin, and Radiation Therapy With or Without Cetuximab in Treating Patients With Locally Advanced Esophageal Cancer National Cancer Institute (NCI) 2009-05-20
Phase IV Mechanisms of Action of Acetaminophen University of Pennsylvania 2009-05-20
Phase I Clofarabine, Melphalan, and Thiotepa Followed By a Donor Stem Cell Transplant in Treating Patients With High-Risk and/or Advanced Hematologic Cancer or Other Disease National Cancer Institute (NCI) 2009-05-20
Phase I Pharmacokinetics of Efavirenz in HIV-1 Infected Subjects With Hepatic Impairment Bristol-Myers Squibb 2009-05-20
Phase I Effect of Rifampin on the Pharmacokinetics of Ixabepilone in Patients With Advanced Cancer Bristol-Myers Squibb 2009-05-20
Phase II Belatacept in Liver Transplant Recipients Bristol-Myers Squibb 2009-05-20
Phase III Entecavir Plus Tenofovir Combination Therapy Versus Entecavir Monotherapy in Naive Subjects With Chronic Hepatitis B Bristol-Myers Squibb 2009-05-20
Phase III A Phase IIIb Study of BMS-188667 in Subjects With Active Rheumatoid Arthritis and Inadequate Response to Methotrexate Bristol-Myers Squibb 2009-05-20
Phase II Study of Ipilimumab to Treat Melanoma in Patients With Brain Metastases Bristol-Myers Squibb 2009-05-20
Phase III Adjuvant Doxorubicin, Cyclophosphamide, and Paclitaxel in Treating Patients With Breast Cancer National Cancer Institute (NCI) 2009-05-20
Phase II Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer National Cancer Institute (NCI) 2009-05-20
Phase III Ablatherm Integrated Imaging High Intensity Focused Ultrasound for the Indication of Low Risk, Localized Prostate Cancer EDAP TMS S.A. 2009-05-20